C-Ray Therapeutics is specialized in providing transformative end-to-end CRDMO services for innovative radiopharmaceuticals and Molecular Imaging CRO services for XDC biotechs. C-Ray offers the full range of services including CMC Development, Pre-clinical evaluation, IIT (Investigator Initiated Trial) translational validation with FIH data generation, IND Enabling, clinical supply and commercial scale cGMP production and supply with reliable logistics.
C-Ray has 28,000 square-meter, state-of-the-art, world class R&D and cGMP manufacturing facilities with the highest Class A Radiation Safety License allowing commercial scale operational volume of over 30+ radioisotopes. GLP-like preclinical study center has both small and big lab animal use permit with animal feeding and administration lab, animal PET/CT for imaging, gama counter and pathology lab for biodistribution and dosimetry analysis. The fully automated cGMP production lines of Lu-177, Ac-225, Cu-64 radio-labelled antibody, peptide and small molecules have been produced for IIT, IND enabling and clinical supply. More than 30 CRDMO projects have been delivered and are actively operated.
